These results may inform research into psychiatric safety and potential repurposing opportunities for GLP-1RAs, especially in people with mental health disorders, but randomized clinical trials are needed to determine whether the genetic associations translate into treatment benefits
[1] Carnitine has no effect on most parameters in end-stage kidney disease, although it may lower C-reactive protein, a biomarker for systemic inflammation
comparing liraglutide 1.2 mg/day + metformin 1000 mg BID with liraglutide 3 mg/day, the combination therapy was effective in reducing fasting glucose and insulin, HOMA-IR, and LDL cholesterol, while only the high dose of liraglutide resulted in a significant improvement of 120 min during OGTT glucose and insulin levels along with a higher weight loss [63]
If you also take the blood thinner warfarin, you may have a higher risk of uncontrolled bleeding
Fitness and Wellness: A Surge in Health-Conscious Consumers The GLP-1 market growth is driving weight loss but also inspiring consumers to adopt healthier lifestyles
BarreaLCaprioMCamajaniEVerdeLPerriniSCignarelliAet al